Patient number | Patient-derived cell line name | Origin | Treatment before sampling |
---|---|---|---|
41 | CTC41 | Blood | None |
44 | CTC44 | Blood | None |
CPP44 | Primary tumour | None | |
45 | CTC45 | Blood | None |
CPP45 | Liver metastasis | None | |
24 | CPP24 | Primary tumour | Bevacizumab Cetuximab FOLFIRI |
25 | CPP25 | Primary tumour | Capecitabine |
19 | CPP19 | Liver metastasis | Bevacizumab FOLFIRI |
30 | CPP30 | Liver metastasis | Bevacizumab FOLFOX4 FOLFIRI Xelox |
CTC, circulating tumour cell.